Genomics, Epidemiology, Diagnostics and Management of Human Respiratory Viruses

278.4K

views

130

authors

20

articles

Genomics, Epidemiology, Diagnostics and Management of Human Respiratory Viruses

278.4K

views

130

authors

20

articles

Editors

2

Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University

St. Anna Children’s Cancer Research Institute (CCRI)

Impact

Fetching...

About

Respiratory viruses include important RNA and DNA pathogens, specifically the Respiratory Syncytial Virus (RSV) A/B, the Influenza Virus (IFV) A/B, the Parainfluenza Virus (PIV) 1-3, the Human Corona-virus (HCoV), the Human Metapneumovirus (HMPV), the Human Rhinovirus (HRV), the Cytomegalovirus (CMV), the Human Bocavirus (HBoV), and the Human Adenovirus (HAdV). These viruses have been implicated in both upper and lower respiratory tract infections which can be associated with considerable morbidity even in immunocompetent individuals. Community-acquired pneumonia (CAP) caused by the viruses is an important respiratory disease and the fifth leading cause of mortality in Europe. In developing countries with close-quartered and/or vulnerable population, CAP poses an even greater risk. Other well documented clinical manifestations include, for example, initiation and acute exacerbation of asthma both in children and adults or bronchiolitis in young infants. In immunocompromised patients such as hematopoietic stem cell transplant (HSCT) or solid organ transplant (SOT) recipients, respiratory viral infections cause life-threatening diseases associated with high mortality. Due to their clinical importance and the limited antiviral treatment options, these viruses pose major clinical challenges.

This Research Topic in Frontiers in Microbiology will feature authoritative articles focusing on select human respiratory viruses and addressing genomic, epidemiological, diagnostic and therapeutic aspects of infections caused by these pathogens. Leading researchers and clinicians are encouraged to present articles and reviews providing state-of-the-art information on respiratory viral infections with a particular focus on human adenoviruses which represent one of the most burning issues in the immunocompromised patient setting.

Respiratory viruses include important RNA and DNA pathogens, specifically the Respiratory Syncytial Virus (RSV) A/B, the Influenza Virus (IFV) A/B, the Parainfluenza Virus (PIV) 1-3, the Human Corona-virus (HCoV), the Human Metapneumovirus (HMPV), the Human Rhinovirus (HRV), the Cytomegalovirus (CMV), the Human Bocavirus (HBoV), and the Human Adenovirus (HAdV). These viruses have been implicated in both upper and lower respiratory tract infections which can be associated with considerable morbidity even in immunocompetent individuals. Community-acquired pneumonia (CAP) caused by the viruses is an important respiratory disease and the fifth leading cause of mortality in Europe. In developing countries with close-quartered and/or vulnerable population, CAP poses an even greater risk. Other well documented clinical manifestations include, for example, initiation and acute exacerbation of asthma both in children and adults or bronchiolitis in young infants. In immunocompromised patients such as hematopoietic stem cell transplant (HSCT) or solid organ transplant (SOT) recipients, respiratory viral infections cause life-threatening diseases associated with high mortality. Due to their clinical importance and the limited antiviral treatment options, these viruses pose major clinical challenges.

This Research Topic in Frontiers in Microbiology will feature authoritative articles focusing on select human respiratory viruses and addressing genomic, epidemiological, diagnostic and therapeutic aspects of infections caused by these pathogens. Leading researchers and clinicians are encouraged to present articles and reviews providing state-of-the-art information on respiratory viral infections with a particular focus on human adenoviruses which represent one of the most burning issues in the immunocompromised patient setting.

Share

Editors

Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University

St. Anna Children’s Cancer Research Institute (CCRI)

Impact

278,407 Total views

248,094 Article views

28,057 Article downloads

2,256 Topic views

Published In

Journal Thumbnail

Frontiers in Microbiology

Virology, Infectious Agents and Disease

Journal Thumbnail

Frontiers in Plant Science

Journal Thumbnail

Frontiers in Medicine

Infectious Agents and Disease

Journal Thumbnail

Frontiers in Public Health

Infectious Agents and Disease

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic